唾液採取・診断の市場規模、シェア、動向分析レポート：採取部位別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

唾液採取・診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の唾液採取・診断の市場規模は、2025年から2030年にかけてCAGR4.7％を記録し、2030年までには11億20万米ドルに達すると推定されています。

伝染性疾患や非伝染性疾患の有病率の増加と、疾患診断のための非侵襲的方法への選好の高まりが背景にあります。さらに、COVID-19に感染した有症状および無症状の患者を診断する必要性の高まりが、市場に大きな機会を生み出しています。2022年8月、PLOS ONEに掲載された調査研究では、口腔液サンプルはその保存性とサンプル採取の容易さから、COVID-19などの様々な診断アッセイに使用できると述べられています。さらに、研究者は、唾液サンプルを28日以上保存しても、信頼性と有用性が保たれるとも述べています。

さらに、2020年には世界のがんおよび関連死亡の負担が増加しましたが、その主な理由は高齢化人口の増加と社会経済的発展です。2020年4月、米国臨床腫瘍学会に掲載された論文によると、世界全体のがんの50％以上が65歳以上で診断されるといいます。そのため、唾液を用いた検査は、がんを発見するための非侵襲的な最良の方法であると考えられています。2022年8月、OrisDXは口腔がんを早期診断・発見する唾液ベースの非侵襲的分子検査の開発を発表しました。

唾液サンプルは、非侵襲的なサンプリング、簡単でシンプルな採取、患者のコンプライアンス向上などの利点があるため、臨床と研究の両方の用途で採用が大きく伸びています。唾液検体には、プロテオミクス分野を前進させるいくつかの進歩や開発が起こっています。例えば、2022年9月、India Todayに掲載された記事によると、IIT Roorkeeの研究者は、転移性トリプルネガティブ乳がんの予測に役立つ唾液タンパク質を特定しました。

この市場で事業を展開する主要企業は、戦略的提携の締結や新製品の発売など、いくつかのイニシアチブをとっており、全体的な成長に貢献しています。例えば、2021年1月、OraSure Technologies, Inc.は、同社の唾液採取装置OMNIgene*ORALがChronomics LimitedのSARS CoV-2 PCR検査に採用されたと発表しました。同様に、2020年8月、Fluidigm Corporationは、唾液ベースの検査であるAdvanta Dx SARS-CoV-2 RT-PCRアッセイのFDA認可を取得したと発表しました。この検査はサンプル中のコロナウイルスの存在を検出するのに役立ちます。

唾液採取・診断市場レポート・ハイライト

• 唾液採取・診断市場全体の成長は、感染症の有病率の増加と、疾患検出のための非侵襲的方法に対する需要の高まりに起因します。
• 採取部位別では、若年層における唾石症例の増加により、顎下腺/舌下腺採取セグメントが2024年の市場を独占しました。
• 用途別では、疾病診断分野が2024年に市場を独占しましたが、これは世界の高齢化人口の増加と、がん、心血管疾患などの疾病事例の増加によるものです。
• 最終用途別では、病気の早期発見に役立つ先端技術の採用とともに診断ラボの数が増加していることから、診断ラボ分野が2024年に最も高い市場シェアを獲得しました。
• 地域別では、北米が2024年に市場を独占しました。これは、複数の市場プレイヤーの存在と、同地域の需要を後押しする政府からの支援の増加によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 唾液採取・診断市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連 / 付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 唾液採取・診断市場分析ツール
  • 業界分析 - ポーターのファイブフォース分析
  • PESTEL分析

第4章 唾液採取・診断市場：採取部位の推定・動向分析

• 収集場所の市場シェア、2024年・2030年
• セグメントダッシュボード
• 世界の唾液採取・診断市場：採取部位別の展望
• 市場規模・予測と動向分析、2018年～2030年
  • 耳下腺採取
  • 顎下腺 / 舌下腺
  • その他

第5章 唾液採取・診断市場：用途の推定・動向分析

• 用途市場シェア、2024年・2030年
• セグメントダッシュボード
• 世界の唾液採取・診断市場：用途別の展望
• 市場規模・予測と動向分析、2018年～2030年
  • 病気の診断
  • 法医学用途
  • 調査

第6章 唾液採取・診断市場：最終用途の推定・動向分析

• 最終用途市場シェア、2024年・2030年
• セグメントダッシュボード
• 世界の唾液採取・診断市場：最終用途別の展望
• 市場規模・予測と動向分析、2018年～2030年
  • 歯科
  • 診断検査室
  • 製薬・バイオテクノロジー企業

第7章 唾液採取・診断市場：地域の推定・動向分析

• 地域別市場シェア分析、2024年・2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 市場規模と予測動向分析、2018年～2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最近の動向と影響分析、主要市場参入企業別
• 企業 / 競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2024年
  • Thermo Fisher Scientific Inc
  • Neogen Corporation
  • Abbott
  • Sarstedt AG &Co.KG
  • Autogen, Inc
  • Oasis Diagnostics
  • Porex
  • Salimetrics, LLC
  • Takara Bio, Inc.

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of abbreviations
• Table 3. North America saliva collection and diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 4. North America saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 5. North America saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 6. North America saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 7. U.S. saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 8. U.S. saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 9. U.S. saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 10. Canada saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 11. Canada saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 12. Canada saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 13. Mexico saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 14. Mexico saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 15. Mexico saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 16. Europe saliva collection and diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 17. Europe saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 18. Europe saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 19. Europe saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 20. Germany saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 21. Germany saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 22. Germany saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 23. UK saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 24. UK saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 25. UK saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 26. France saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 27. France saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 28. France saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 29. Italy saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 30. Italy saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 31. Italy saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 32. Spain saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 33. Spain saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 34. Spain saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 35. Denmark saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 36. Denmark saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 37. Denmark saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 38. Sweden saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 39. Sweden saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 40. Sweden saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 41. Norway saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 42. Norway saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 43. Norway saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 44. Asia Pacific saliva collection and diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 45. Asia Pacific saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 46. Asia Pacific saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 47. Asia Pacific saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 48. China saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 49. China saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 50. China saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 51. Japan saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 52. Japan saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 53. Japan saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 54. India saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 55. India saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 56. India saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 57. South Korea saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 58. South Korea saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 59. South Korea saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 60. Australia saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 61. Australia saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 62. Australia saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 63. Thailand saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 64. Thailand saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 65. Thailand saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 66. Latin America saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 67. Latin America saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 68. Latin America saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 69. Brazil saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 70. Brazil saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 71. Brazil saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 72. Argentina saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 73. Argentina saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 74. Argentina saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 75. MEA saliva collection and diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 76. MEA saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 77. MEA saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 78. MEA saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 79. South Africa saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 80. South Africa saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 81. South Africa saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 82. Saudi Arabia saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 83. Saudi Arabia saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 84. Saudi Arabia saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 85. UAE saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 86. UAE saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 87. UAE saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 88. Kuwait saliva collection and diagnostics market, by site of collection, 2018 - 2030 (USD Million)
• Table 89. Kuwait saliva collection and diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 90. Kuwait saliva collection and diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1. Information procurement
• Fig. 2. Primary research pattern
• Fig. 3. Market research approaches
• Fig. 4. Value chain-based sizing & forecasting
• Fig. 5. Market formulation & validation
• Fig. 6. Saliva Collection and Diagnostics market segmentation
• Fig. 7. Market driver analysis (current & future impact)
• Fig. 8. Market restraint analysis (current & future impact)
• Fig. 9. SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 10. Porter's five forces analysis
• Fig. 11. Saliva Collection and Diagnostics market: Site of Collection movement analysis
• Fig. 12. Parotid gland collection market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 13. Submandibular/Sublingual Gland Collection market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14. Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15. Saliva Collection and Diagnostics market: Application movement analysis
• Fig. 16. Disease Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17. Forensic Applications market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18. Research market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19. Dentistry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20. Saliva Collection and Diagnostics market: End-use movement analysis
• Fig. 21. Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22. Pharmaceutical & Biotechnology Companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23. Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24. North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29. UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31. France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38. China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40. India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47. Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52. Market share of key market players- Saliva Collection and Diagnostics market

Saliva Collection And Diagnostics Market Growth & Trends:

The global saliva collection and diagnostics market size is estimated to reach USD 1,100.2 million by 2030, registering a CAGR of 4.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Owing to the increasing prevalence of communicable and non-communicable diseases along with the increasing preference for non-invasive methods for disease diagnosis. Moreover, the growing need to diagnose COVID-19-infected symptomatic and asymptomatic patients have created significant opportunities for the market. In August 2022, a research study published in PLOS ONE stated that oral fluid samples could be used for various diagnostic assays, such as COVID-19, due to its storage and ease of sample collection. Moreover, researchers have also stated that even if the salivary samples were stored for more than 28 days, it would remain reliable and useful.

Furthermore, the global burden of cancer and related deaths rose in 2020, majorly because of the increasing aging population and socioeconomic development. In April 2020, an article published in the American Society of clinical oncology stated that more than 50% of cancers globally are diagnosed in people aged 65 and older. Therefore, the saliva-based test is considered to be the best non-invasive procedure to detect cancer. In August 2022, OrisDX announced of developing a saliva-based non-invasive molecular test to diagnose and detect oral cancer at an early stage which would help in improving patient outcomes.

There has been significant growth in the adoption of saliva samples for both clinical and research applications as it offers non-invasive sampling, easy, simple collection, and higher patient compliance, among others. Several advancements and developments are happening in saliva specimens which would advance the proteomics field. For instance, in September 2022, an article published in India Today stated that researchers from IIT Roorkee identified salivary proteins which could help in predicting metastatic triple-negative breast cancer.

Key players operating in the market are taking several initiatives such as entering into strategic alliances and launching new products which are contributing to the overall growth. For instance, in January 2021, OraSure Technologies, Inc. announced that its saliva collection device, OMNIgene*ORAL, has been selected by Chronomics Limited for the SARS CoV-2 PCR test. Similarly, in August 2020, Fluidigm Corporation announced receiving FDA authorization for its saliva-based test, Advanta Dx SARS-CoV-2 RT-PCR assay. This test would help to detect the presence of coronavirus in the sample.

Saliva Collection And Diagnostics Market Report Highlights:

• The growth of the overall saliva collection and diagnostics market is attributed to the increasing prevalence of infectious diseases along with the growing demand for non-invasive methods for disease detection
• By site of collection, the submandibular/sublingual gland collection segment dominated the market in 2024, owing to the increasing cases of sialoliths among the young population
• By application, the disease diagnostics segment dominated the market in 2024 owing to the increasing aging population globally coupled with increasing cases of diseases such as cancer, cardiovascular diseases, and others
• By end use, the diagnostic laboratories segment captured the highest market share in 2024, owing to the growing number of diagnostic labs along with the introduction of advanced technology which could help in the early detection of diseases
• By region, North America dominated the market in 2024 owing to the presence of several market players along with increasing support from the government to boost the demand in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Site of Collection
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Site of collection outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
• 2.3. Competitive Insights

Chapter 3. Saliva Collection and Diagnostics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing cases of infectious disease
    • 3.2.1.2. Rising application of non-invasive saliva testing method
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of skilled professionals to operate saliva collection devices
• 3.3. Saliva Collection and Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Saliva Collection and Diagnostics Market: Site of Collection Estimates & Trend Analysis

• 4.1. Site of Collection Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Saliva Collection and Diagnostics Market by Site of Collection Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Parotid Gland Collection
    • 4.4.1.1. Parotid gland collection market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Submandibular/Sublingual Gland
    • 4.4.2.1. Submandibular/Sublingual Gland market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Others
    • 4.4.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Saliva Collection and Diagnostics Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Saliva Collection and Diagnostics Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Disease diagnostics
    • 5.4.1.1. Disease diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Forensic applications
    • 5.4.2.1. Forensic applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Research
    • 5.4.3.1. Research market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Saliva Collection and Diagnostics Market: End-Use Estimates & Trend Analysis

• 6.1. End-Use Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Saliva Collection and Diagnostics Market by End-Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Dentistry
    • 6.4.1.1. Dentistry market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Diagnostic Laboratories
    • 6.4.2.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Pharmaceutical & Biotechnology Companies
    • 6.4.3.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Saliva Collection and Diagnostics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key company market share analysis, 2024
  • 8.3.2. Thermo Fisher Scientific Inc
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Neogen Corporation
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Abbott
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Sarstedt AG & Co.KG
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Autogen, Inc
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Oasis Diagnostics
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Porex
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Salimetrics, LLC
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Takara Bio, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives